InvestorsHub Logo
Followers 2
Posts 1299
Boards Moderated 0
Alias Born 12/10/2016

Re: BioHunter post# 4344

Tuesday, 06/27/2017 8:56:06 AM

Tuesday, June 27, 2017 8:56:06 AM

Post# of 8795
Well, if it's large shareholders bailing on a company after a failed drug trial that renders hundreds of millions of dollars in NOLs worthless, wouldn't it be smart and profitable to only bail on 49% of the company? They might use ACXW/PIOE as a case study!

In most cases biotech companies will undergo one or more Ownership Changes after a drug fails and larger shareholders bail out. Once this happens, it is almost impossible to remedy the NOL usage limitation.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PX News